Institutional Ownership Amylyx Pharmaceuticals, Inc. (AMLX)
This table provides information about the institutional ownership of Amylyx Pharmaceuticals, Inc. (AMLX). We have compiled data on the 127 institutions that hold shares in the stock, with a total of 44.4 Million shares, which have been reported (via 13F filing form) to have a value of $177 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
456,816
shares
|
$1.83 Million
0.0% of portfolio
|
Q3 2024
Reduced 70.24%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
406,157
shares
|
$1.62 Million
0.0% of portfolio
|
Q3 2024
Reduced 8.94%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
367,237
shares
|
$1.47 Million
0.0% of portfolio
|
Q3 2024
Reduced 71.7%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
344,173
shares
|
$1.38 Million
0.0% of portfolio
|
Q3 2024
Reduced 29.92%
|
|
|
Ghost Tree Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
325,000
shares
|
$1.3 Million
0.39% of portfolio
|
Q3 2024
New holding
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
309,500
shares
|
$1.24 Million
0.0% of portfolio
|
Q3 2024
Reduced 73.18%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
302,270
shares
|
$1.21 Million
0.0% of portfolio
|
Q3 2024
Reduced 42.05%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
295,000
shares
|
$1.18 Million
1.83% of portfolio
|
Q3 2023
Added 1080.0%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
283,986
shares
|
$1.14 Million
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2024 Q3 2024 |
274,551
shares
|
$1.1 Million
0.16% of portfolio
|
Q2 2024
Reduced 17.17%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
271,800
shares
|
$1.09 Million
0.0% of portfolio
|
Q3 2024
Reduced 66.51%
|
|
|
Aldebaran Capital, LLC
Indianapolis, IN |
Nov 13, 2024 Q3 2024 |
269,803
shares
|
$1.08 Million
0.8% of portfolio
|
Q2 2024
New holding
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
229,076
shares
|
$916,304
0.0% of portfolio
|
Q3 2024
Added 660.07%
|
|
|
First Trust Advisors LP
Wheaton, IL |
Nov 13, 2024 Q3 2024 |
221,626
shares
|
$886,504
0.0% of portfolio
|
Q3 2024
Added 59.33%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2024 Q3 2024 |
220,906
shares
|
$883,624
0.12% of portfolio
|
Q3 2024
Added 105.87%
|
|
|
Panagora Asset Management Inc
Boston, MA |
Nov 13, 2024 Q3 2024 |
188,465
shares
|
$753,860
0.0% of portfolio
|
Q2 2024
Reduced 0.29%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 13, 2024 Q3 2024 |
186,286
shares
|
$745,144
0.0% of portfolio
|
Q3 2024
Added 4.2%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
183,894
shares
|
$735,576
0.0% of portfolio
|
Q3 2024
Reduced 76.7%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
166,429
shares
|
$665,716
0.0% of portfolio
|
Q3 2024
Added 670.5%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
154,908
shares
|
$619,632
0.0% of portfolio
|
Q2 2024
Reduced 92.48%
|
|
|
Bank Of Montreal
Toronto, A6 |
Nov 13, 2024 Q3 2024 |
143,512
shares
|
$574,048
0.0% of portfolio
|
Q3 2024
Added 36.35%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
140,559
shares
|
$562,236
0.0% of portfolio
|
Q3 2024
Added 144.4%
|
|
|
Man Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
130,862
shares
|
$523,448
0.0% of portfolio
|
Q3 2024
Added 12.69%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Nov 14, 2024 Q3 2024 |
130,000
shares
|
$520,000
0.01% of portfolio
|
Q2 2024
New holding
|
|
|
Group One Trading, L.P.
Chicago, IL |
Nov 14, 2024 Q3 2024 |
129,290
shares
|
$517,160
0.02% of portfolio
|
Q3 2024
Reduced 55.31%
|